KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Elanco Animal Health (ELAN) Leases (2018 - 2025)

Elanco Animal Health's Leases history spans 7 years, with the latest figure at $226.0 million for Q4 2025.

  • For Q4 2025, Leases changed N/A year-over-year to $226.0 million; the TTM value through Dec 2025 reached $226.0 million, changed N/A, while the annual FY2025 figure was $226.0 million, N/A changed from the prior year.
  • Leases for Q4 2025 was $226.0 million at Elanco Animal Health, up from $140.0 million in the prior quarter.
  • Across five years, Leases topped out at $226.0 million in Q4 2025 and bottomed at $140.0 million in Q4 2023.
  • The 4-year median for Leases is $151.0 million (2021), against an average of $167.0 million.
  • The largest annual shift saw Leases fell 13.9% in 2021 before it fell 0.71% in 2023.
  • A 4-year view of Leases shows it stood at $161.0 million in 2021, then dropped by 12.42% to $141.0 million in 2022, then dropped by 0.71% to $140.0 million in 2023, then surged by 61.43% to $226.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Leases are $226.0 million (Q4 2025), $140.0 million (Q4 2023), and $141.0 million (Q4 2022).